Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of Type 1 diabetes

Hormone and Metabolic Research

Volumn 31, Issue 10, 1999, Pages 553-557

  Hampe, C S ^a   Ortqvist E ^b   Persson, B ^b   Schranz, D B ^a   Lernmark, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibodies; Autoimmunity; Epitope Spreading

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CHILD; DIABETES MELLITUS; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SERUM;

EID: 0032747140     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978794     Document Type: Article

References (28)

1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619-633
2. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-822
3. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-independent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387-395
4. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A. Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-1511
5. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339
6. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156
7. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark Å. A novel radioligand binding assay to determine diagnostic accuracy of isoformspecific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-350
8. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Bärmeier H, Mathewes S, Grant FJ, Foster D, Lernmark Ä. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci US 1991; 88: 8337-8341
9. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37000- and 40000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995; 96: 1506-1511
10. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PM. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994; 152: 3183-3187
11. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933
12. r autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1357-1360
13. Baekkeskov S, Landin-Olsson M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundkvist G, Lernmark Å. Antibodies to a Mr 64000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987; 79: 926-934
14. Hampe CS, Örtqvist E, Rolandsson O, Landin-Olsson M, Törn C, Ågren Å, Persson B, Schranz DB, Lernmark Å. Species specific autoantibodies in Type 1 diabetes. J Clin Invest 1999; 84: 643-648
15. Bu D-F, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wanger-McPherson CB, Evans GA, Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci 1992; 89: 2115-2119
16. Lee DS, Tian J, Phan T, Kaufman DL Cloning and sequence analysis of a murine cDNA encoding glutamate decarboxylase (GAD65). Biochim Biophys Acta 1993; 1216: 157-160
17. 3H recombinant human ligands. J Immunol Methods 1995; 186: 89-99
18. Bonifacio E, Lernmark Å, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Meth. 1988; 106: 83-88
19. Lernmark Å, Molenaar JL, vanBeers WAM, Yamaguchi Y, Nagataki S, Ludvigsson J, Maclaren NK. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. In: Diabetologia, (ed). IDW Workshop. Nagasaki, Japan: Springer-Verlag, 1991
20. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167-169
21. Christie M, Landin-OIsson M, Sundkvist G, Dahlquist G, Lernmark A, Baekkeskov S. Antibodies to a Mr 64000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 1988; 31: 597-602
22. Hagopian WA, Michelsen B, Karlsen AE, Larsen F. Moody A, Grubin CE, Rowe R, Petersen J, McEvoy R, Lernmark A. Autoantibodies in IDDM primarily recognize the 65000-Mr rather than the 67000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993:42:631-636
23. Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J, Eisenbarth GS. Anti islet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996; 81: 4264-4267
24. Kawasaki E. Yu L, Rewers MJ, Hutton JC, Eisenbarth GS. Definition of multiple ICA512/phogrin autoantibodyepitopesand detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes 1998; 47: 733-742
25. Daw K, Powers AC. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes. Diabetes 1995; 44: 216-220
26. Richter W, Shi Y, Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993; 90: 2832-2836
27. Falorni A, Ackefors M, Carlberg C, Daniels T, Persson B, Robertson J, Lernmark Å. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM. Diabetologia 1996; 39: 1091-1098
28. Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type 1 diabetes. Diabetes 1994; 43: 968-975